Protocol IM119-013: A Phase IIa randomised, double-blind, placebo controlled study to evaluate the clinical efficacy, safety and pharmacokinetics of three different doses of BMS 582949 given orally... (2008)
Experts
Professor
Peter Soyer
Centre Director of Dermatology Research Centre
Dermatology Research Centre
Faculty of Health, Medicine and Behavioural Sciences
Affiliate of Queensland Digital Health Centre
Queensland Digital Health Centre
Faculty of Health, Medicine and Behavioural Sciences
Professorial Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences